Related references
Note: Only part of the references are listed.Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes
Adilson Guilherme et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Phyllanthus urinaria ameliorates the severity of nutritional steatohepatitis both in vitro and in vivo
Bo Shen et al.
HEPATOLOGY (2008)
Adipokines as emerging mediators of immune response and inflammation
Francisca Lago et al.
NATURE CLINICAL PRACTICE RHEUMATOLOGY (2007)
The effects of discontinuing pioglitazone in patients with nonalcoholic steatohepatitis
Glen Lutchman et al.
HEPATOLOGY (2007)
Effects of rosiglitazone on the liver histology and mitochondrial function in ob/ob mice
Inmaculada Garcia-Ruiz et al.
HEPATOLOGY (2007)
Peroxisome Proliferator-Activated Receptor (PPAR) in Metabolic Syndrome and Type 2 Diabetes Mellitus
Mollie A. Jay et al.
CURRENT DIABETES REVIEWS (2007)
A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis
Renata Belfort et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Metabolic and adipokine profile of chinese patients with nonalcoholic fatty liver disease
Vincent Wai-Sun Wong et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
COX-2 induction in mice with experimental nutritional steatohepatitis:: Role as pro-inflammatory mediator
J Yu et al.
HEPATOLOGY (2006)
Nutrition-/diet-induced changes in gene expression in white adipose tissue
H Al-Hasani et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Adiponectin and adiponectin receptors
T Kadowaki et al.
ENDOCRINE REVIEWS (2005)
Administration of the potent PPARα agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in mice
E Ip et al.
HEPATOLOGY (2004)
PPARs and the complex journey to obesity
RM Evans et al.
NATURE MEDICINE (2004)
Drug therapy: Thiazolidinediones
H Yki-Jarvinen
NEW ENGLAND JOURNAL OF MEDICINE (2004)
PPARγ influences susceptibility to DMBA-induced mammary, ovarian and skin carcinogenesis
CJ Nicol et al.
CARCINOGENESIS (2004)
Cytokines and NASH: A pilot study of the effects of lifestyle modification and vitamin E
M Kugelmas et al.
HEPATOLOGY (2003)
The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice
AM Xu et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Non-alcoholic steatohepatitis: What is it, and why is it important in the Asia-Pacific region?
GC Farrell
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2003)
Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor γ1 (PPARγ1) overexpression
ST Yu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Interleukin-6 induces cellular insulin resistance in hepatocytes
JJ Senn et al.
DIABETES (2002)
A futile metabolic cycle activated in adipocytes by antidiabetic agents
HP Guan et al.
NATURE MEDICINE (2002)
Conditional disruption of the peroxisome proliferator-activated receptor γ gene in mice results in lowered expression of ABCA1, ABCG1, and apoE in macrophages and reduced cholesterol efflux
TE Akiyama et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Mechanisms by which both heterozygous peroxisome proliferator-activated receptor γ (PPARγ) deficiency and PPARγ agonist improve insulin resistance.
T Yamauchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus
AD Pradhan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Mechanisms of disease: Cytokines in alcoholic and nonalcoholic steatohepatitis.
H Tilg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
